The founders of Medigate, which Claroty acquired for around $400 million in 2021, are now starting a new cybersecurity company.
Jonathan Langer and Itay Kirshenbaum have left Claroty to team up with Stephen Goldberg, a former senior executive at Claroty, and Ilai Fallach, a veteran of several cybersecurity companies, to start a new venture that is currently in stealth mode.
The company, currently named ACT, has raised $20 million in a Seed funding round from investors such as Team8 and U.S. venture capital firm Bessemer Venture Partners.
ACT will be led by Langer, former COO of Claroty; Goldberg, who will be Chief Product Officer; Kirshenbaum, the company’s Chief Technology Officer; and Fallach.
The company’s goal is to go beyond just visibility and vulnerability disclosure, offering security teams practical tools to take effective action and reduce risks in cloud environments.
Medigate, founded in 2017 by Langer, Kirshenbaum, and Pini Pinhasov, had raised only $50 million before being acquired. The company built a dedicated cybersecurity platform for medical devices, also known as the Internet of Medical Things (IoMT), used in hospitals and healthcare facilities.
Its technology solved a key problem: many medical devices—like monitors, CT scanners, and infusion pumps—are connected to hospital networks but are not well protected by standard security solutions.
Claroty works in cybersecurity for essential services and critical infrastructure. Last year, there were market rumours that the company might go public with an IPO valued at $3.5 billion, with annual revenue estimated at around $400 million.
Read more- Graas.ai Gets $9M in Pre-Series B Funding
